Uno studio su Guselkumab rispetto a Risankizumab in partecipanti con malattia di Crohn da moderatamente a severamente attiva (CHARGE)
Studio di fase 3b, multicentrico, randomizzato, in aperto, controllato attivo, per confrontare l'efficacia e la sicurezza di Guselkumab rispetto a Risankizumab nel trattamento di partecipanti con malattia di Crohn da moderata a severamente attiva
The purpose of this study is to assess how well guselkumab works when compared to risankizumab in participants with moderately to severely active Crohn's Disease (CD; a long-term condition causing severe inflammation of the intestinal tract).
Panoramica dello studio
Stato
Stato
Condizioni
Condizioni
Intervento / Trattamento
Intervento / Trattamento
Tipo di studio
Tipo di studio
Iscrizione (Stimato)
Iscrizione
Fase
Fase
- Fase 3
Contatti e Sedi
Contatto studio
Contatto studio
- Nome: Study Contact
- Numero di telefono: 844-434-4210
- Email: Participate-In-This-Study1@its.jnj.com
Luoghi di studio
-
-
-
Graz, Austria, 8036
- Reclutamento
- LKH-Univ. Klinikum Graz
-
Innsbruck, Austria, 6020
- Reclutamento
- Medizinische Universitatsklinik Innsbruck
-
Linz, Austria, 4021
- Reclutamento
- Kepler Universitatsklinikum GmbH
-
Salzburg, Austria, 5020
- Reclutamento
- LKH - Universitätsklinikum der PMU Salzburg
-
Vienna, Austria, 1090
- Reclutamento
- Medical University Vienna
-
Vienna, Austria, 1020
- Reclutamento
- Krankenhaus der Barmherzigen Brüder
-
Wels, Austria, 4600
- Reclutamento
- Klinikum Wels Grieskirchen
-
Wiener Neustadt, Austria, 2700
- Reclutamento
- Universitatsklinikum Wiener Neustadt
-
-
-
-
-
Brussels, Belgio, 1200
- Reclutamento
- Cliniques Universitaires Saint Luc
-
Brussels, Belgio, 1070
- Reclutamento
- ULB Erasme Ziekenhuis
-
Genk, Belgio, 3600
- Reclutamento
- Ziekenhuis Oost-Limburg
-
Ghent, Belgio, 9000
- Reclutamento
- Ghent University Hospital
-
Leuven, Belgio, 3000
- Reclutamento
- Universitair Ziekenhuis Leuven
-
Liège, Belgio, 4000
- Reclutamento
- CHU de Liege
-
Roeselare, Belgio, 8800
- Reclutamento
- Algemeen Ziekenhuis Delta
-
-
-
-
Alberta
-
Edmonton, Alberta, Canada, T5R 1W2
- Reclutamento
- Gastroenterology and Internal Medicine Research Institute (GIRI)
-
-
British Columbia
-
Vancouver, British Columbia, Canada, V6Z 2K5
- Reclutamento
- GIRI Gastrointestinal Research Institute
-
-
Ontario
-
Hamilton, Ontario, Canada, L8N1Y2
- Reclutamento
- Charlton Digestive Disease Centre
-
London, Ontario, Canada, N6K 1M6
- Reclutamento
- London Digestive Disease Institute
-
Oshawa, Ontario, Canada, L1J 0C7
- Reclutamento
- Taunton Surgical Centre
-
Toronto, Ontario, Canada, M6A 3B4
- Reclutamento
- Toronto Immune and Digestive Health Institute Inc
-
-
Quebec
-
Montreal, Quebec, Canada, H3H1E3
- Reclutamento
- Clinique IMD
-
Montreal, Quebec, Canada, H2X 0C1
- Reclutamento
- Centre Hospitalier de l'Universite de Montreal
-
-
-
-
-
Brno, Cechia, 62500
- Reclutamento
- Fakultni nemocnice Brno
-
Brno, Cechia, 636 00
- Reclutamento
- Vojenska nemocnice Brno
-
Hradec Kralova, Cechia, 500 02
- Reclutamento
- Gastroenterologie, s.r.o., Hradec Kralove
-
Hradec Králové, Cechia, 500 12
- Reclutamento
- Hepato-gastroenterologie HK, s.r.o.
-
Ostrava-Poruba, Cechia, 708 00
- Reclutamento
- Fakultni Nemocnice Ostrava
-
Prague, Cechia, 100 00
- Reclutamento
- Fakultni nemocnice Kralovske Vinohrady
-
Prague, Cechia, 14000
- Reclutamento
- Fakultni Thomayerova nemocnice
-
-
-
-
-
Changzhou, Cina, 213018
- Reclutamento
- Changzhou No 2 Peoples Hospital
-
Chongqing, Cina, 400014
- Reclutamento
- Chongqing General Hospital
-
Fuzhou, Cina, 350005
- Reclutamento
- The First Affiliated Hospital of Fujian Medical University
-
Guangzhou, Cina, 510655
- Reclutamento
- The Sixth Affiliated Hospital Sun Yat sen University
-
Guangzhou, Cina, 510261
- Reclutamento
- The Second Affiliated Hospital of Guangzhou Medical University
-
Nanjing, Cina, 210009
- Reclutamento
- Zhongda Hospital Southeast University
-
Wuhan, Cina, 430060
- Reclutamento
- Renmin Hospital of Wuhan University
-
-
-
-
-
Aarhus C, Danimarca, 8200
- Reclutamento
- Aarhus University Hospital
-
Esbjerg, Danimarca, 6700
- Reclutamento
- Sydvestjysk Sygehus
-
Gistrup, Danimarca, 9260
- Reclutamento
- NAU New Aalborg University Hospital
-
Herlev, Danimarca, 2730
- Reclutamento
- Herlev Hospital
-
Hilleroed, Danimarca, 3400
- Reclutamento
- Nordsjaellands Hospital, Hillerod
-
Hvidovre, Danimarca, 2650
- Reclutamento
- Hvidovre Hospital
-
København NV, Danimarca, 2400
- Reclutamento
- Bispebjerg Hospital
-
Odense C, Danimarca, 5000
- Reclutamento
- Odense UH og Svendberg sygehus
-
-
-
-
-
Amiens, Francia, 80000
- Reclutamento
- CHU Amiens Picardie
-
Clermont-Ferrand, Francia, 63000
- Reclutamento
- Clermont Ferrand University Hospital
-
Marseille, Francia, 13015
- Reclutamento
- Aphm - Hopital Nord
-
Nantes, Francia, 44000
- Reclutamento
- CHU Nantes - Hotel Dieu
-
Neuilly-sur-Seine, Francia, 92200
- Reclutamento
- Clinique Ambroise Pare
-
Nîmes, Francia, 30900
- Reclutamento
- CHU Nimes
-
Paris, Francia, 75018
- Reclutamento
- APHP - Hopital Bichat - Claude Bernard
-
Paris, Francia, 75012
- Reclutamento
- Aphp Hopital Saint Antoine
-
Pierre-Bénite, Francia, 69495
- Reclutamento
- Hospices Civils de Lyon CHU Lyon Sud
-
Reims, Francia, 51100
- Reclutamento
- CHU de Reims
-
Vandœuvre-lès-Nancy, Francia, 54511
- Reclutamento
- Centre Hospitalier Universitaire de Nancy - Hôpital Central
-
Échirolles, Francia, 38130
- Reclutamento
- Institut Prive MICI Clinique des Cedres
-
-
-
-
-
Berlin, Germania, 10825
- Reclutamento
- GASTRO-Studien
-
Berlin, Germania, 12203
- Reclutamento
- Charite Universitaetsmedizin Berlin - Campus Benjamin Franklin (CBF)
-
Erlangen, Germania, 91054
- Reclutamento
- Universitatsklinikum Erlangen
-
Grevenbroich, Germania, 41515
- Reclutamento
- Praxiszentrum Fur Gastroenterologie und Endoskopie Grevenbroich
-
Jena, Germania, 07747
- Reclutamento
- Universitatsklinikum Jena
-
Kiel, Germania, 24105
- Reclutamento
- Universitatsklinikum Schleswig Holstein Kiel
-
Ludwigshafen am Rhein, Germania, 67067
- Reclutamento
- St. Marien und St. Annastiftskrankenhaus
-
Mannheim, Germania, 68167
- Reclutamento
- Universitaetsklinikum Mannheim
-
München, Germania, 81675
- Reclutamento
- Klinikum rechts der Isar der TU Munchen
-
-
-
-
-
Bologna, Italia, 40138
- Reclutamento
- A O U Sant Orsola Malpighi
-
Bolzano, Italia, 39100
- Reclutamento
- Azienda Sanitaria dell'Alto Adige - Ospedale di Bolzano
-
Genova, Italia, 16132
- Reclutamento
- Azienda Ospedaliero Universitaria San Martino
-
Milan, Italia, 20132
- Reclutamento
- IRCCS Ospedale San Raffaele
-
Roma, Italia, 00168
- Reclutamento
- Fondazione Policlinico Universitario A Gemelli IRCCS
-
Rozzano, Italia, 20089
- Reclutamento
- Istituto Clinico Humanitas
-
Torino, Italia, 10128
- Reclutamento
- Ospedale Mauriziano Torino
-
-
-
-
-
Maastricht, Olanda, 6229 HX
- Reclutamento
- Maastricht UMC
-
Nijmegen, Olanda, 6525 GA
- Reclutamento
- Radboud Umcn
-
Tilburg, Olanda, 5022 GC
- Reclutamento
- St. Elisabeth Ziekenhuis
-
-
-
-
-
Bydgoszcz, Polonia, 85 229
- Reclutamento
- Centrum Medyczne Medis ManerMed Sp Z O O
-
Krakow, Polonia, 30363
- Reclutamento
- Centrum Medyczne Plejady
-
Krakow, Polonia, 31-513
- Reclutamento
- Centrum Medyczne Promed
-
Rzeszów, Polonia, 35-326
- Reclutamento
- Centrum Medyczne 'Medyk' Sp. z o.o. K.
-
Szczecin, Polonia, 71-434
- Reclutamento
- Twoja Przychodnia - Szczecinskie Centrum Medyczne
-
Torun, Polonia, 87 100
- Reclutamento
- GASTROMED Kopon Zmudzinski i wspolnicy SP j Specjalistyczne Centrum Gastrologii i Endoskopii
-
Warsaw, Polonia, 02-781
- Reclutamento
- Narodowy Instytut Onkologii im Marii Sklodowskiej Curie Panstwowy Instytut Badawczy
-
Warsaw, Polonia, 04 501
- Reclutamento
- Medical Network Sp z o o
-
-
-
-
-
Greater London, Regno Unito, E1 2AJ
- Reclutamento
- Barts Health NHS Trust
-
Greater London, Regno Unito, NW10 7NS
- Reclutamento
- London North West University Healthcare NHS Trust
-
Iselworth, Regno Unito, TW7 6AF
- Reclutamento
- West Middlesex University Hospital
-
London, Regno Unito, NW3 2QG
- Reclutamento
- Royal Free Hospital
-
London, Regno Unito, W120HS
- Reclutamento
- Imperial College London
-
London, Regno Unito, NW1 2PG
- Reclutamento
- University College London Hospitals Nhs Foundation Trust
-
London, Regno Unito, SW10 9NH
- Reclutamento
- Chelsea And Westminster Hospital
-
Norwich, Regno Unito, NR4 7UQ
- Reclutamento
- Norfolk and Norwich University Hospital
-
Wolverhampton, Regno Unito, WV10 0QP
- Reclutamento
- New Cross Hospital
-
-
-
-
-
Banská Bystrica, Slovacchia, 975 17
- Reclutamento
- FNsP F. D. Roosevelta Banska Bystrica
-
Bratislava, Slovacchia, 811 09
- Reclutamento
- Cliniq s.r.o.
-
Košice, Slovacchia, 040 13
- Reclutamento
- ENDOMED s.r.o
-
Nové Zámky, Slovacchia, 940 34
- Reclutamento
- Fakultna nemocnica s poliklinikou Nove Zamky
-
Prešov, Slovacchia, 080 01
- Reclutamento
- GASTRO I. s.r.o.
-
Prešov, Slovacchia, 080 01
- Reclutamento
- Gastro LM s.r.o.
-
Rimavská Sobota, Slovacchia, 979 12
- Reclutamento
- Vseobecna nemocnica Rimavska Sobota
-
-
-
-
-
Alicante, Spagna, 03010
- Reclutamento
- Hosp. Gral. Univ. Dr. Balmis
-
Barcelona, Spagna, 08036
- Reclutamento
- Hosp. Clinic de Barcelona
-
Ferrol, Spagna, 15405
- Reclutamento
- Hosp. Arquitecto Marcide
-
Gijón, Spagna, 33394
- Reclutamento
- Hosp. de Cabuenes
-
Girona, Spagna, 17007
- Reclutamento
- Hosp. Univ. Dr. Josep Trueta
-
Madrid, Spagna, 28850
- Reclutamento
- Hosp. Univ. de Torrejon
-
Navarra, Spagna, 31008
- Reclutamento
- Hosp. de Navarra
-
Santiago de Compostela, Spagna, 15706
- Reclutamento
- Hosp. Clinico Univ. de Santiago
-
Seville, Spagna, 41009
- Reclutamento
- Hosp. Virgen Macarena
-
-
-
-
Alabama
-
Dothan, Alabama, Stati Uniti, 36305
- Reclutamento
- Digestive Health Specialists of the Southeast
-
Mobile, Alabama, Stati Uniti, 36608
- Reclutamento
- East View Medical Research
-
-
California
-
Anaheim, California, Stati Uniti, 92805
- Reclutamento
- Clinnova Research
-
Lancaster, California, Stati Uniti, 93534
- Reclutamento
- Gastro Care Institute
-
Los Alamitos, California, Stati Uniti, 90720
- Reclutamento
- United Gastroenterologists
-
Los Angeles, California, Stati Uniti, 90048
- Reclutamento
- TLC Clinical Research Inc
-
Los Angeles, California, Stati Uniti, 90067
- Reclutamento
- GastroIntestinal Bioscience
-
San Diego, California, Stati Uniti, 92123
- Reclutamento
- Medical Associates Research Group, Inc.
-
-
Colorado
-
Colorado Springs, Colorado, Stati Uniti, 80907
- Reclutamento
- Peak Gastroenterology Associates
-
-
Connecticut
-
Hamden, Connecticut, Stati Uniti, 06518
- Reclutamento
- Medical Research Center of Connecticut
-
-
Florida
-
Jacksonville, Florida, Stati Uniti, 32258
- Reclutamento
- Green Leaf Clinical Trials
-
Miami, Florida, Stati Uniti, 33157-6575
- Reclutamento
- Sanchez Clinical Research, Inc
-
Miami, Florida, Stati Uniti, 33186
- Reclutamento
- Biodax Medical Research Trials
-
Naples, Florida, Stati Uniti, 34102
- Reclutamento
- GI Pros Research
-
Orlando, Florida, Stati Uniti, 32806
- Reclutamento
- Orlando Health Digestive Health Institute
-
Tampa, Florida, Stati Uniti, 33609
- Reclutamento
- GCP Clinical Research
-
-
Georgia
-
Atlanta, Georgia, Stati Uniti, 30310
- Reclutamento
- Morehouse School of Medicine
-
Atlanta, Georgia, Stati Uniti, 30342
- Sospeso
- Atlanta Gastroenterology Associates
-
Macon, Georgia, Stati Uniti, 31201
- Reclutamento
- Gastroenterology Associates of Central GA
-
-
Illinois
-
Northbrook, Illinois, Stati Uniti, 60062
- Reclutamento
- Comprehensive Gastrointestinal Health Libertyville
-
-
Iowa
-
Clive, Iowa, Stati Uniti, 50325
- Reclutamento
- Heartland Medical Research Inc
-
-
Kansas
-
Topeka, Kansas, Stati Uniti, 66606
- Reclutamento
- Cotton-O'Neil Clinical Research Center
-
-
Louisiana
-
Lafayette, Louisiana, Stati Uniti, 70503
- Reclutamento
- Gastroenterology Clinic of Acadiana
-
Shreveport, Louisiana, Stati Uniti, 71103
- Reclutamento
- Louisiana State University Health Sciences Center Shreveport
-
-
Maryland
-
Glen Burnie, Maryland, Stati Uniti, 21061
- Reclutamento
- Woodholme Gastroenterology Associates
-
-
Massachusetts
-
New Bedford, Massachusetts, Stati Uniti, 02740
- Reclutamento
- Lucida Clinical Trials
-
-
Michigan
-
Farmington Hills, Michigan, Stati Uniti, 48334
- Reclutamento
- Michigan Center of Medical Research
-
-
New York
-
Carmel, New York, Stati Uniti, 10512
- Reclutamento
- Westchester Putnam Gastroenterology
-
New York, New York, Stati Uniti, 10028
- Reclutamento
- New York Gastroenterology Associates
-
New York, New York, Stati Uniti, 10075
- Sospeso
- Lenox Hill Hospital
-
-
North Carolina
-
Chapel Hill, North Carolina, Stati Uniti, 27599 7080
- Reclutamento
- University of North Carolina at Chapel Hill
-
Charlotte, North Carolina, Stati Uniti, 28207
- Reclutamento
- Charlotte Gastroenterology and Hepatology, PLLC
-
-
Ohio
-
Mentor, Ohio, Stati Uniti, 44060
- Reclutamento
- Great Lakes Gastroenterology Research, LLC
-
-
Oklahoma
-
Oklahoma City, Oklahoma, Stati Uniti, 73114
- Reclutamento
- Digestive Disease Specialists Inc
-
-
Pennsylvania
-
Uniontown, Pennsylvania, Stati Uniti, 15401
- Reclutamento
- Frontier Clinical Research
-
-
South Carolina
-
Summerville, South Carolina, Stati Uniti, 29486
- Reclutamento
- Palmetto Primary and Specialty Care Physicians, Charleston
-
-
Texas
-
Carrollton, Texas, Stati Uniti, 75010
- Reclutamento
- DFW Clinical Trials
-
Lubbock, Texas, Stati Uniti, 79424
- Reclutamento
- Lubbock Gastroenterology
-
San Antonio, Texas, Stati Uniti, 78229
- Reclutamento
- Gastroenterology Research of America, LLC
-
San Antonio, Texas, Stati Uniti, 78229
- Reclutamento
- Southern Star Research Institute, LLC
-
Tyler, Texas, Stati Uniti, 75708
- Reclutamento
- The University of Texas Health Science Center at Tyler
-
-
-
-
-
Linköping, Svezia, 58185
- Reclutamento
- Linkoping University Hospital
-
Mölndal, Svezia, 431 30
- Reclutamento
- Sahlgrenska Universitetssjukhuset, Mölndal Sjukhus
-
Stockholm, Svezia, 171 76
- Reclutamento
- Karolinska Universitetssjukhuset
-
Stockholm, Svezia, 116 30
- Reclutamento
- Ersta sjukhus
-
Stockholm, Svezia, 118 83
- Reclutamento
- Sodersjukhuset
-
Uppsala, Svezia, 751 85
- Reclutamento
- Akademiska Sjukhuset
-
-
-
-
-
Budapest, Ungheria, 1088
- Reclutamento
- Semmelweis Egyetem
-
Budapest, Ungheria, 1036
- Reclutamento
- Obudai Egeszsegugyi Centrum Kft
-
Budapest, Ungheria, H-1136
- Reclutamento
- Pannónia Magánorvosi Centrum Kft
-
Budapest, Ungheria, 1082
- Reclutamento
- Semmelweis Egyetem 1
-
Budapest, Ungheria, 1083
- Reclutamento
- Semmelweis Egyetem 2
-
Budapest, Ungheria, 1139
- Reclutamento
- Endomedix
-
Gyöngyös, Ungheria, 3200
- Reclutamento
- Clinexpert Gyongyos Kft
-
Szeged, Ungheria, 6725
- Reclutamento
- Szegedi Tudomanyegyetem
-
-
Criteri di partecipazione
Criteri di ammissibilità
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion criteria:
-
Has CD or fistulizing Crohn's Disease (CD) of at least 12 weeks' duration, with colitis, ileitis, or ileocolitis, confirmed at some time in the past by radiography, histology, and/or endoscopy
-
Have moderately to severely active CD, defined as baseline Crohn's Disease Activity Index (CDAI) score greater than or equal to (>=) 220 but less than or equal to (<=) 450
-
Baseline endoscopic evidence of active ileal and/or colonic CD as assessed by central endoscopy reading at the screening endoscopy defined as a screening Simple Endoscopic Score for Crohn's Disease (SES CD) >= 4 (for participants with isolated ileal disease) or >= 6 (for participants with colonic or ileocolonic disease), based on the presence of ulceration in any 1 of the 5 ileocolonic segments, resulting in the following specified ulceration component scores:
- a minimum score of 1 for the component of "size of ulcers" AND
- a minimum score of 1 for the component of "ulcerated surface"
-
In the opinion of the investigator, participant's disease is appropriate to treat with the maintenance dosing regimens utilized in the study
-
Adhere to the requirements for concomitant medications for the treatment of CD as mentioned in the protocol
Exclusion criteria
- Has complications of CD such as symptomatic strictures or stenoses, short gut syndrome, active draining stoma or significant fistulizing disease or any other manifestation anticipated to require surgery within the next year, could preclude the use of the CDAI to assess response to therapy, or would possibly confound the ability to assess the effect of treatment with guselkumab or risankizumab
- Currently has or is suspected to have an abscess
- Has an active fistula during screening or at Week 0 with an anticipated need for surgery
- Has had any kind of bowel resection within 24 weeks, or any other intra-abdominal or other major surgery within 12 weeks, before first dose of study intervention
- Currently has a malignancy or has a history of malignancy within 5 years before screening
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Numero di armi
Armi e interventi
Gruppo di partecipanti / ArmGruppo di partecipanti / Arm |
Intervento / TrattamentoIntervento / Trattamento |
|---|---|
|
Sperimentale: Guselkumab
Participants will receive guselkumab induction dose subcutaneously (SC) at Weeks 0, 4, and 8 followed by guselkumab maintenance dose SC once every 4 weeks (q4w) from Week 12 through Week 52. |
Guselkumab will be administered.
Altri nomi:
|
|
Sperimentale: Risankizumab
Participants will receive risankizumab induction dose intravenously (IV) at Weeks 0, 4, and 8 followed by risankizumab maintenance dose SC once every 8 weeks (q8w) from Week 12 through Week 52. |
Risankizumab will be administered. |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Number of Participants with Deep Remission at Week 52
Lasso di tempo: At Week 52
|
Deep remission is a composite endpoint defined as achieving both clinical remission and endoscopic remission at the participant level. Clinical remission is defined as Crohn's Disease Activity Index (CDAI) score less than (<) 150-point. CDAI will be assessed by collecting information on 8 different CD-related variables: extra-intestinal manifestations, abdominal mass, weight, hematocrit, total number of liquid stools, abdominal pain/cramping, use of antidiarrheal drug(s), and/or opiates, and general well-being. In general, CDAI score ranges from 0 to approximately 600. Higher score indicates higher disease activity. Endoscopic remission is defined as Simple Endoscopic Score for Crohn's Disease (SES-CD) less than or equal to (<=) 4 with at least a 2-point reduction from baseline and no sub score greater than (>) 1 in any individual component and score can range from 0 to 56. Higher scores indicating severe disease. |
At Week 52
|
Misure di risultato secondarie
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Composite Endpoint of Number of Participants with Clinical Remission and Endoscopic Response at Week 52
Lasso di tempo: At Week 52
|
Clinical remission is defined as CDAI score < 150-point. CDAI will be assessed by collecting information on 8 different CD-related variables: extra-intestinal manifestations, abdominal mass, weight, hematocrit, total number of liquid stools, abdominal pain/cramping, use of antidiarrheal drug(s), and/or opiates, and general well-being. In general, CDAI score ranges from 0 to approximately 600. Higher score indicates higher disease activity. Endoscopic response is defined as >50 percent (%) improvement from baseline in the SES CD or SES-CD score <= 2 or a decrease of at least 2 points in participants with a baseline score of 4 and isolated ileal disease. This is a composite endpoint defined to measure achievement of both clinical remission and endoscopic response. |
At Week 52
|
|
Number of Participants with Endoscopic Remission at Week 52
Lasso di tempo: At Week 52
|
Endoscopic remission is defined as SES-CD <= 4 with at least a 2-point reduction from baseline and no sub score > 1 in any individual component and score can range from 0 to 56. Higher scores indicating severe disease. |
At Week 52
|
|
Number of Participants with Clinical Remission at Week 52
Lasso di tempo: At Week 52
|
Clinical remission is defined as CDAI score < 150-point. CDAI will be assessed by collecting information on 8 different CD-related variables: extra-intestinal manifestations, abdominal mass, weight, hematocrit, total number of liquid stools, abdominal pain/cramping, use of antidiarrheal drug(s), and/or opiates, and general well-being. In general, CDAI score ranges from 0 to approximately 600. Higher score indicates higher disease activity. |
At Week 52
|
|
Number of Participants with Steroid-Free Clinical Remission at Week 52
Lasso di tempo: At Week 52
|
Steroid-free clinical remission is defined as clinical remission at Week 52 and not receiving corticosteroids for at least 90 days prior to Week 52. Clinical remission is defined as CDAI score < 150-point. |
At Week 52
|
|
Number of Participants with Abnormalities in Laboratory Parameters
Lasso di tempo: Up to Week 148
|
Number of participants with abnormalities in laboratory parameters (hematology and chemistry) will be reported. |
Up to Week 148
|
|
Number of Participants With Change From Baseline in Laboratory Abnormalities
Lasso di tempo: Up to week 148
|
Number of participants with change from baseline in laboratory abnormalities (hematology and chemistry) will be reported. |
Up to week 148
|
|
Number of Participants with Adverse Events (AEs), Serious AEs and AEs Leading to Discontinuation of Study Intervention
Lasso di tempo: Up to Week 165
|
An AE is any untoward medical occurrence in a participant administered a pharmaceutical (investigational or non investigational) product. An AE does not necessarily have a causal relationship with the treatment. An SAE is any untoward medical occurrence that at any dose results in death, is life-threatening, requires inpatient hospitalization or prolongation of existing hospitalization, results in persistent or significant disability/incapacity, is a congenital anomaly/birth defect, is a suspected transmission of any infectious agent via a medicinal product and is medically important. |
Up to Week 165
|
Collaboratori e investigatori
Sponsor
Sponsor
Investigatori
Investigatori
- Direttore dello studio: Janssen Research & Development, LLC Clinical Trial, Janssen Research & Development, LLC
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Inizio studio
Completamento primario (Stimato)
Completamento primario
Completamento dello studio (Stimato)
Completamento dello studio
Date di iscrizione allo studio
Primo inviato
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Primo Inserito
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento pubblicato
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
Altri numeri di identificazione dello studio
- CNTO1959CRD3009
- CNTO1959CRD3009 (Altro identificatore: Janssen Research & Development, LLC)
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Descrizione del piano IPD
The data sharing policy of Johnson & Johnson Innovative Medicine is available at www.innovativemedicine.jnj.com/our-innovation/clinical-trials/transparency. As noted on this site, requests for access to the study data can be submitted through Yale Open Data Access (YODA) Project site at yoda.yale.edu.
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
prodotto fabbricato ed esportato dagli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .